The largest community of pharma leaders

Prevail Therapeutics Announces Executive Team Promotion and Appointments to Board of Directors

NEW YORK–(BUSINESS WIRE)–Prevail Therapeutics Inc. (Prevail), a gene therapy company developing AAV-based gene therapies for patients with devastating neurodegenerative diseases, today announced the promotion of Yong Dai, Ph.D., to Chief Technology Officer. In this role, Dr. Dai will lead the Company’s process development and analytical development to establish advanced manufacturing. In addition, the Company has appointed Tim Adams, Chief Financial Officer of ObsEva, to its Board of Director….

Recent Articles